Candel Therapeutics, Inc.

CADL

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Baker Bros. Advisors

Position history (shares)

Baker Bros. Advisors

2Q

2 quarters

Position Trend

May 15, 2025

$13.8M

1 fund

Aug 14, 2025

$1.8M

1 fund

Nov 14, 2025

$0

0 funds

Feb 17, 2026

$0

0 funds

-100% total institutional value over 4 quarters

Short Interest

Short Shares

14.18M

Change

+52.6%

Days to Cover

8.6

% of Float

22.9%

Settlement

Mar 13, 2026

Short interest over 2 periods

Catalysts

No catalysts tracked.

Position Details

Baker Bros. AdvisorsEXITFeb 17, 2026

Shares: 0Value: N/A

Baker Bros. AdvisorsEXITNov 14, 2025

Shares: 355,112Value: $1.8M

+ 2more — see how much conviction went in

See the Full Story

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

BNTX1 fund FDMT1 fund ABSI1 fund ALKS1 fund ARGX1 fund RCUS1 fund ARWR1 fund BCRX1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: